Getting personal: a patient-centred approach to rare disease drug development
Driving peptide development and manufacturing
The roadmap to success in the cannabinoid drug development journey
Diagnosing hormone-based disorders using saliva
The right validation model: practical considerations and applications
Analytical method development in a high potent facility
Investing in a manufacturing infrastructure to harness tumour-infiltrating lymphocytes (TILs) for cancer treatment
Simplifying technology transfer to get drugs to market faster
Bio-Courier: a new delivery technology to increase the global accessibility of RNA therapeutics
What’s in a partner? The essential facets of a strong biopharma collaboration